The American biotechnology company Moderna announced on November 16 that its Covid vaccine is 94.5% effective. The US-German collaboration of Pfizer and BioNTech had previously made a similar announcement. These two “mRNA” vaccines are the most promising candidates undergoing phase 3 human trials now, and the vaccines could begin in …
Read More »